Nika Pharmaceuticals NIKA
OTC NIKA
$0.41 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Nika Pharmaceuticals, Inc (NIKA) Liabilities and Shareholders Equity (2021 - 2023)

Updated

Nika Pharmaceuticals' Liabilities and Shareholders Equity was $864.00 in Q4 2023, unchanged from $864.00 a year earlier and down 92.1% from the prior quarter.

Analysis

Nika Pharmaceuticals, Inc (NIKA) Liabilities and Shareholders Equity (2021 - 2023) Analysis & Trends

From Q4 2021 onward, Nika Pharmaceuticals has reported Liabilities and Shareholders Equity for 9 quarters.

  • In earlier years, Liabilities and Shareholders Equity was $864.00 in FY2022 (+116.5%) and $399.00 in FY2021.
  • Quarterly Liabilities and Shareholders Equity has moved between $83.00 (Q1 2022) and $11,053 (Q2 2023) over five years.
  • Compared with a year earlier, Liabilities and Shareholders Equity was higher in three of the last four quarters, with growth averaging 81.2%.
  • Per Business Quant data, NIKA's Liabilities and Shareholders Equity in the three quarters before Q4 2023 was $10,910 (Q3 2023), $11,053 (Q2 2023) and $4,459 (Q1 2023).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 864.00
Sep 30, 2023 10,910.00
Jun 30, 2023 11,053.00
Mar 31, 2023 4,459.00
Dec 31, 2022 864.00
Sep 30, 2022 3,914.00
Jun 30, 2022 8,545.00
Mar 31, 2022 83.00
Dec 31, 2021 399.00
API Access

Nika Pharmaceuticals, Inc Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=NIKA&period=max&api_key=YOUR_API_KEY